NEWS

Metabolys Inc’s presentation at 3rd Annual World Preclinical Congress Europe 2018 in Lisbon, Portugal.

News Release 2018.11.30

SMC announced that Metabolys Inc. presented results of a study using STAM model at 3rd Annual World Preclinical Congress Europe 2018 in Lisbon, Portugal, November 28-29, 2018.

Title: “MTBL0036, a Promising, New Anti-NASH and Antifibrotic Candidate: MTBL0036 showed a decrease in NAFLD Activity score in the STAM model”